Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for...

Dr Sandra Swain - Washington Cancer Institute, Washington, USA

Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for HER2-positive metastatic breast cancer ( Dr Sandra Swain - Washington Cancer Institute, Washington, USA )

Adding cediranib to chemo improves PFS for metastatic cervical cancer

Dr Paul Symonds - University Hospital of Leicester, Leicester, UK

Adding cediranib to chemo improves PFS for metastatic cervical cancer ( Dr Paul Symonds - University Hospital of Leicester, Leicester, UK )

New horizons in prostate cancer: The final results of the COU-302 abiraterone...

Prof Charles Ryan and Prof Gordon McVie

New horizons in prostate cancer: The final results of the COU-302 abiraterone study ( Prof Charles Ryan and Prof Gordon McVie )

Reducing nausea and vomiting associated with cisplatin-based chemotherapy with...

Dr Bernardo Leon Rapoport - The Medical Oncology Centre, Johannesburg, South...

Reducing nausea and vomiting associated with cisplatin-based chemotherapy with rolapitant ( Dr Bernardo Leon Rapoport - The Medical Oncology Centre, Johannesburg, South Africa )

The evolving treatment landscape for HER2-positive metastatic breast cancer

Dr Hatem Azim - Institut Jules Bordet, Brussels, Belgium

The evolving treatment landscape for HER2-positive metastatic breast cancer ( Dr Hatem Azim - Institut Jules Bordet, Brussels, Belgium )

Navigating current treatment options for HER2-positive MBC: Patient journey 1

Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria

Navigating current treatment options for HER2-positive MBC: Patient journey 1 ( Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria )

Overview of skin cancer treatments, past, present and future

Prof John Hawk - President of the World Congress on Cancers of the Skin 2014

Overview of skin cancer treatments, past, present and future ( Prof John Hawk - President of the World Congress on Cancers of the Skin 2014 )

Advances in CLL: Expert panel Discussion

Prof Robin Foà ; Prof Clemens Wendtner; Dr Francesc Bosch; Prof Florence...

Advances in CLL: Expert panel Discussion ( Prof Robin Foà ; Prof Clemens Wendtner; Dr Francesc Bosch; Prof Florence Cymbalista )

Emerging treatments in CLL: Expert Discussion

Prof Robin Foà and Prof Peter Hillmen

Emerging treatments in CLL: Expert Discussion ( Prof Robin Foà and Prof Peter Hillmen )

Melanoma live: Making patient-focused therapy decisions

Prof Dirk Schadendorf; Dr Paul Nathan; Prof Georgina Long

Melanoma live: Making patient-focused therapy decisions ( Prof Dirk Schadendorf; Dr Paul Nathan; Prof Georgina Long )

Repurposing generics to fight cancer and the work of the ReDO Project

Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium

Repurposing generics to fight cancer and the work of the ReDO Project ( Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium )

Continual low-dose metronomic chemotherapy as potentially preferable to...

Prof Yuval Shaked - Israel Institute of Technology, Haifa, Israel

Continual low-dose metronomic chemotherapy as potentially preferable to aggressive strategies ( Prof Yuval Shaked - Israel Institute of Technology, Haifa, Israel )

More from ecancer